Koyfin Home > Directory > Health Care > Akebia Therapeutics > EV / Sales (ntm)

Akebia Therapeutics EV / Sales (ntm) Chart (AKBA)

Akebia Therapeutics annual/quarterly EV / Sales (ntm) from 2014 to 2020.
  • Akebia Therapeutics EV / Sales (ntm) for the quarter ending September 09, 2020 was 0.81 a -10.87% decrease of -0.09 year over year
  • Akebia Therapeutics EV / Sales (ntm) for the last 12 months ending September 09, 2020 was 0.81 a -10.87% decrease of -0.09 year over year
  • Akebia Therapeutics Annual EV / Sales (ntm) for 2020 was 0.81 a -2.04% decrease of -0.02 from 2019
  • Akebia Therapeutics Annual EV / Sales (ntm) for 2020 was 0.83 a 1.33% increase of 0.01 from 2019
  • Akebia Therapeutics Annual EV / Sales (ntm) for 2020 was 0.82 a -10.12% decrease of -0.08 from 2019
Other Valuation Metrics:
  • Akebia Therapeutics Market Cap for the quarter ending March 03, 2018 was $535m a -24.92% decrease of -133m year over year
  • Akebia Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.80 a -378.76% decrease of -14.40 year over year
  • Akebia Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $217m a -91.84% decrease of -199m year over year
View Chart On Koyfin

Quarterly AKBA EV / Sales (ntm) Data

09/20200.81
09/20200.83
09/20200.82
09/20200.90
09/20200.75
09/20200.73
09/20200.76
09/20200.67
09/20200.71
09/20200.74

Annual AKBA EV / Sales (ntm) Data

20200.81
20200.83
20200.82
20200.90
20200.75
20200.73
20200.76
20200.67
20200.71
20200.74